References
- Barbagallo J., Tager P., Ingleton R., Hirsch R. J., Weinberg J. M. Cutaneous tuberculosis: Diagnosis and the treatment. Am J Clin Dermatol 2002; 3: 319–28
- Fine P. E. BCG: The challenge continues. Scan J Infect Dis 2001; 33: 243–5
- Kassouf W., Kamat A. M. Current state of immunotherapy for bladder cancer. Expert Rev Anticancer Ther 2004; 4: 1037–46
- Talbot E. A., Perkins M. D., Silva S. F., Frothingham R. Disseminated bacilli Calmette–Guérin disease after vaccination: Case report and review. Clin Infect Dis 1997; 24: 1139–46
- Koya M. P., Simon M. A., Soloway M. S. Complications of intravesical therapy for urothelial cancer of the bladder. J Urol 2006; 175: 2004–10
- Lamm D. L., van der Meijden P. M., Morales A., Brosman S. A., Catalona W. J., Herr H. W., et al. Incidence and treatment of complications of bacillus Calmette–Guérin intravesical therapy in superficial bladder cancer. J Urol 1992; 147: 596–600
- Sepkowitz K. A. Tuberculosis and the health care worker: A historical perspective. Ann Intern Med 1994; 120: 71–9
- Menzies D., Fanning A., Yuan L., Fitzgerald M. Tuberculosis among health care workers. N Engl J Med 1995; 332: 92–8
- Atiyeh B. S., Wazzan W. C., Kaddoura I. L., Saghir M. B., Zaatari A. M., Hamdan A. M. Bacille Calmette–Guérin (BCG) – it is of the hand: A potential hazard for health workers. Ann Plast Surg 1996; 36: 325–10
- Janier M., Gheorghiu M., Cohen P., Mazas F., Duroux P. [Carpal tunnel syndrome due to Mycobacterium bovis BCG.]. Sem Hop 1982; 58: 977–9
- Steg A., Leleu C., Debré B., Boccon‐Gibod L., Sicard D. Systemic bacillus Calmette–Guérin infection in patients treated by intravascular BCG therapy for superficial bladder cancer. Prog Clin Biol Res 1989; 310: 325–34
- Pinocy J., Eingartner C., Ruck P., Weise K. [Recurrent soft tissue infections after accidental inoculation with BCG vaccine.]. Unfallchirurg 1998; 101: 658–60